Sponsors may have been excited to expand the US Food and Drug Administration’s INTERACT meeting program, but many are finding it difficult to access, in part because the acceptance requirements remain a regulatory gray area.
INTERACT Meeting Timing Remains Point Of Confusion
US FDA review divisions will determine whether the meeting is appropriate because there are no one-size-fits-all requirements.
